Genitourinary Cancer

SS 13 - GU 2 -Prostate Post-op, Prognostic Factors and High Risk

9/16/2019
10:45 AM - 12:00 PM
Location: Room W183

Session Type: Scientific
1.25 AMA PRA Category 1 Credits™
1.25 CAMPEP Credits

Presentations:

Alan Dal Pra, MD

University of Miami

Disclosure:
Employment
University of Miami: Radiation Oncology: Employee

Leadership
ESTRO: ESTRO-ACROP: Advisory Committee in Radiation Oncology Practice for Prostate Cancer;
SAKK: Principal Investigator: Principal Investigator in clinical trials

Biography:
Dr. Alan Dal Pra is Assistant Professor of Radiation Oncology and Associate Director of Clinical Research at the Department of Radiation Oncology, Sylvester Comprehensive Cancer Center at the University of Miami, Miller School of Medicine. He also serves as Medical Director of the Radiation Oncology Unit at The Lennar Foundation Medical Center. He specializes in Genitourinary Oncology. Dr. Dal Pra obtained his Medical Degree from the Federal University of Rio Grande do Sul and underwent Radiation Oncology specialty training in Brazil and Canada. He has postdoctoral training and fellowships in Genitourinary Oncology at McGill University and at the Princess Margaret Cancer Centre, University of Toronto, where he completed training in Genitourinary Translational Oncology. He is the principal investigator of a European multicenter trial and investigator or co-investigator of several prospective studies in Genitourinary Oncology. Dr. Dal Pra is the recipient of numerous research grants and has coauthored articles appearing in Nature, Nature Genetics, European Urology, Lancet Oncology, Clinical Cancer Research, Red Journal, and other peer-reviewed journals. He serves as an ad-hoc reviewer for several high-profile journals and as Associate Editor for the British Journal of Radiology.

Presentation(s):

Send Email for Alan Dal Pra

Alison Tree, MBBS, BSc, FRCR, MD(Res)

The Royal Marsden NHS Foundation Trust

Disclosure:
Employment
Institute of Cancer Research: Associate Honorary Faculty: Employee;
Royal Marsden NHS Foundation Trust: Consultant Clinical Oncologist: Employee

Compensation
Accuray: Research Grants;
Elekta: Honoraria: Research Grants: Travel Expenses;
MSD: Research Grants

Leadership
Elekta MR Linac consortium: Prostate theme lead and institutional lead: To coordinate prostate research efforts on the MR Linac and to oversee the overall consortium activities;
NCRI Prostate Clinical Studies Group: Committee member: Attend strategy meetings, give feedback to investigators on their proposed trials.;
UK SABR consortium: Executive board member: Support and organisation for annual meeting and other ad hoc meetings/projects

Biography:
Alison Tree was appointed as a consultant clinical oncologist at the Royal Marsden hospital in 2014, specialising in urological malignancies. She holds an Associate honorary faculty position at the Institute of Cancer Research. Her MD thesis was on stereotactic radiotherapy techniques for prostate and oligometastatic cancer.
She is on the UK NCRI Prostate CSG and UK SABR consortium committees, is CI of the TRAP and PRISM studies and co-investigator of the PACE, CORE, PIVOTALboost and InPACT trials. Her research has received funding from Prostate Cancer UK, the Rosetrees Trust, the JP Moulton foundation and Elekta. She is prostate lead for the MR Linac consortium. Her current research interests include technical radiotherapy improvements in prostate cancer and oligometastatic disease. 

Presentation(s):

Send Email for Alison Tree


Assets

SS 13 - GU 2 -Prostate Post-op, Prognostic Factors and High Risk



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for SS 13 - GU 2 -Prostate Post-op, Prognostic Factors and High Risk